SCHEMBL5164562

SCHEMBL5164562

NC(=O)c1cccc(NC(C(=O)Nc2ccc(N3CCCCC3=O)cc2)c2ccccc2)c1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 5/20 0.86
KMT2A Q03164 5/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
MEN1 O00255 3/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
TSHR P16473 1/20 0.53
ALDH1A1 P00352 3/20 0.48
TP53 P04637 1/20 0.48
GLA P06280 1/20 0.48
PKM P14618 1/20 0.48
GAA P10253 1/20 0.47
GFER P55789 1/20 0.47
KDM1A O60341 1/20 0.46
MAOB P27338 1/20 0.46
MAPT P10636 5/20 0.46
KDM4E B2RXH2 1/20 0.46
POLB P06746 1/20 0.46
CYP1A2 P05177 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5167183 1.00 F10 (0.86) F10KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL5166588 1.00 F10 (0.86) F10KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL5164649 0.99 F10 (0.85) F10KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL5166204 0.93 F10 (1.00) F10KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL5165960 0.93 F10 (1.00) F10KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL5371292 0.92 F10 (0.98) F10KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL6808410 0.90 F10 (0.95) F10KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL5164064 0.90 F10 (0.95) F10KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL5164626 0.88 F10 (0.82) F10KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL5165647 0.88 F10 (0.82) F10KMT2ASMN1; SMN2MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US claimed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP claimed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US claimed
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US disclosed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP disclosed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087582-A1 Phenyl derivatives F2, F11, SERPINC1 F10 6/4885KMT2A 2252/4885SMN1; SMN2 3430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.